Keyphrases
Skeletal muscle
100%
NF-B
100%
Muscle Atrophy
100%
Skeletal muscle Atrophy
41%
Glucocorticoid-induced
33%
Atrogin-1
25%
Overexpression
16%
Muscle Fiber
16%
MuRF1
16%
Overexpressing
8%
MRNA Expression
8%
Chronic Disease
8%
Forelimb
8%
Acute Disease
8%
Knockdown
8%
Standard of Care
8%
Methylprednisolone
8%
Adenoviral Vector
8%
Intramuscular Injection
8%
Catabolic
8%
Multiple Injections
8%
Human Skeletal muscle
8%
Systemic Inflammation
8%
Recombinant Human
8%
Tibialis Anterior muscle
8%
Atrophy
8%
Myostatin
8%
Glucocorticoid Therapy
8%
Pathophysiological Mechanisms
8%
As(III)
8%
Fiber Cross-sectional Area
8%
In Vivo Expression
8%
Myotubes
8%
GADD45A
8%
Unintended Consequences
8%
Limb Weakness
8%
Skeletal muscle Proteolysis
8%
Frontline Therapy
8%
Glucocorticoid Injection
8%
Medicine and Dentistry
Phosphotransferase
100%
Muscle Atrophy
100%
Glucocorticoid
100%
Skeletal Muscle
100%
Skeletal Muscle Atrophy
41%
Atrogin 1
25%
Biological Marker
16%
Messenger RNA
16%
Mediator
8%
Side Effect
8%
Chronic Disease
8%
Methylprednisolone
8%
Protein Degradation
8%
Tibialis Anterior Muscle
8%
Myostatin
8%
Intramuscular Injection
8%
Acute Disease
8%
Adenovirus Vector
8%
Myotube
8%
Forelimb
8%
Limb Weakness
8%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Glucocorticoid
100%
Muscle Atrophy
100%
Atrogin 1
25%
Biological Marker
16%
Messenger RNA
16%
Chronic Disease
8%
Side Effect
8%
Acute Disease
8%
Inflammation
8%
Methylprednisolone
8%
Adenovirus Vector
8%
Myostatin
8%
Limb Weakness
8%
Intramuscular Injection
8%